Literature DB >> 823575

Influence of pheniramine and chlorpheniramine on apomorphine induced compulsive gnawing in mice.

N K Dadkar, A N Dohadwalla, B K Bhattacharya.   

Abstract

In mice, apomorphine (10 mg/kg s.c.) does not induce a compulsion to gnaw, but pretreatment with antihistamines, viz. pheniramine, chlorpheniramine and mepyramine, in doses ranging from 30 to 60 mg/kg i.p. caused gnawing activity. Mepyramine showed significantly less effect when compared to the other two agents. Antihistamines are known to influence the activity of biogenic amines in central nervous system. The potentiation of apomorphine-induced gnawing by antihistamines might depend upon the reciprocal balance between dopaminergic and cholinergic systems. This was tested by blocking biosynthesis of biogenic amines or by blocking their receptors. The potentiation of gnawing was antagonised by physostigmine (0.25 mg/kg) or blocked by pretreatment with alpha-methyl-p-tyrosine (alpha-MPT) (4 X 150 mg/kg) and bis-(4-methyl-1-homopiperazinylthiocarbonyl)-disulphide (FLA) (40 mg/kg), while p-chlorophenyl alanine (p-CPA) (3 X 100 mg/kg) had no effect. Similarly, phenoxybenzamine (30 mg/kg) and haloperidol (1.0 mg/kg) inhibited gnawing activity, but methysergide (10 mg/kg) had no effect. Furthermore, pretreatment with tetrabenazine (20 mg/kg) and L-Dopa (200 mg/kg) did not affect gnawing activity. It is concluded that both pheniramine and chlorpheniramine potentiate apomorphine gnawing by upsetting the cholinergic and dopaminergic balance in favour of dopaminergic dominance.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823575     DOI: 10.1007/BF00423299

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  [Apomorphine synergism (inducedgnawing in mice) as a test for the differentiation of psychotropic substances].

Authors:  L THER; H SCHRAMM
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-07-01

2.  Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain.

Authors:  H Nybäck; J Schubert; G Sedvall
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

3.  Effect of central stimulants and depressants on mouse brain acetylcholine and choline levels.

Authors:  S Consolo; H Ladinsky; G Peri; S Garattini
Journal:  Eur J Pharmacol       Date:  1972-05       Impact factor: 4.432

4.  The mechanism of the potentiation of norepinephrine by antihistaminics.

Authors:  L Isaac; A Goth
Journal:  J Pharmacol Exp Ther       Date:  1967-06       Impact factor: 4.030

5.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

6.  Apomorphine and central serotonin neurons.

Authors:  M Grabowska; L Antkiewicz; J Maj; J Michaluk
Journal:  Pol J Pharmacol Pharm       Date:  1973 Jan-Feb

7.  Effect of oxotremorine and physostigmine on choline levels in mouse whole brain, spleen and cerebellum.

Authors:  H Ladinsky; S Consolo; G Peri
Journal:  Biochem Pharmacol       Date:  1974-04-01       Impact factor: 5.858

8.  Role of catecholaminesi in compulsive gnawing behaviour in mice.

Authors:  V Pedersen
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

9.  Antiparkinsonian drugs and central dopamine neurons.

Authors:  K Fuxe; M Goldstein; A Ljungdahl
Journal:  Life Sci I       Date:  1970-07-15

10.  Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.

Authors:  T H Svensson
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

View more
  2 in total

1.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

2.  Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice.

Authors:  N K Dadkar; A N Dohadwalla; B K Bhattacharya
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.